NO960231L - Kondensert benzazepinderivat og farmasöytisk preparat derav - Google Patents

Kondensert benzazepinderivat og farmasöytisk preparat derav

Info

Publication number
NO960231L
NO960231L NO960231A NO960231A NO960231L NO 960231 L NO960231 L NO 960231L NO 960231 A NO960231 A NO 960231A NO 960231 A NO960231 A NO 960231A NO 960231 L NO960231 L NO 960231L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
benzazepine derivative
condensed benzazepine
condensed
derivative
Prior art date
Application number
NO960231A
Other languages
English (en)
Other versions
NO960231D0 (no
NO306303B1 (no
Inventor
Akihiro Tanaka
Hiroyuki Koshio
Nobuaki Taniguchi
Akira Matsuhisa
Ken-Ichiro Sakamoto
Atsuki Yamazaki
Takeyuki Yatsu
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO960231D0 publication Critical patent/NO960231D0/no
Publication of NO960231L publication Critical patent/NO960231L/no
Publication of NO306303B1 publication Critical patent/NO306303B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Output Control And Ontrol Of Special Type Engine (AREA)
NO960231A 1993-07-21 1996-01-19 Kondensert benzazepinderivat og farmasöytisk preparat derav NO306303B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18043593 1993-07-21
PCT/JP1994/001183 WO1995003305A1 (en) 1993-07-21 1994-07-19 Fused benzazepine derivative and pharmaceutical composition containing the same

Publications (3)

Publication Number Publication Date
NO960231D0 NO960231D0 (no) 1996-01-19
NO960231L true NO960231L (no) 1996-03-21
NO306303B1 NO306303B1 (no) 1999-10-18

Family

ID=16083198

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960231A NO306303B1 (no) 1993-07-21 1996-01-19 Kondensert benzazepinderivat og farmasöytisk preparat derav

Country Status (18)

Country Link
US (2) US5723606A (no)
EP (2) EP0709386B1 (no)
KR (1) KR100304331B1 (no)
CN (1) CN1040210C (no)
AT (2) ATE239726T1 (no)
AU (2) AU683483B2 (no)
CA (1) CA2167673C (no)
DE (2) DE69432632T2 (no)
ES (2) ES2198418T3 (no)
FI (1) FI113178B (no)
HU (1) HUT74582A (no)
NO (1) NO306303B1 (no)
NZ (1) NZ268671A (no)
PL (1) PL177738B1 (no)
RU (1) RU2129123C1 (no)
TW (1) TW279163B (no)
UA (1) UA64690C2 (no)
WO (1) WO1995003305A1 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693635A (en) * 1993-07-29 1997-12-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5760031A (en) * 1993-07-29 1998-06-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AR002459A1 (es) * 1995-01-17 1998-03-25 American Cyanamid Co Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
KR20010034461A (ko) * 1998-01-28 2001-04-25 요시다 쇼지 시기능 장해의 예방 또는 치료제
AR018818A1 (es) * 1998-04-03 2001-12-12 Yamano Masaki Una composicion farmaceutica para la terapia de un edema.
AU4168999A (en) * 1998-06-19 2000-01-05 Wakamoto Pharmaceutical Co., Ltd. Ocular tension lowering agents and phosphoric ester derivatives
RU2250899C2 (ru) * 1999-01-19 2005-04-27 Орто-Макнейл Фармасьютикал, Инк. Трициклические бензодиазепины, фармацевтическая композиция на их основе и способы лечения гипертензии
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
US6765004B1 (en) 1999-06-17 2004-07-20 Ortho-Mcneil Pharmaceutical, Inc. Indoloazepines as vasopressin receptor antagonists
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US6645959B1 (en) 2000-01-26 2003-11-11 Warner-Lambert Company Method for treating postoperative ileus
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
WO2001054677A2 (en) * 2000-01-26 2001-08-02 Warner-Lambert Company Ace inhibitor-vasopressin antagonist combinations
US20030008860A1 (en) * 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
AU779929B2 (en) * 2000-10-04 2005-02-17 Warner-Lambert Company Treatment of pulmonary hypertension
EP1195166B1 (en) 2000-10-04 2007-07-25 Astellas Pharma Inc. Use of a vasopressin antagonist such as conivaptan in the manufacture of a medicament for treating pulmonary hypertension
CA2425892A1 (en) * 2000-11-28 2003-04-11 Hiroyuki Koshio 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivative or salt thereof
EP1632494A1 (en) * 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
US7671221B2 (en) * 2005-12-28 2010-03-02 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
AU2006336504C9 (en) * 2005-12-28 2015-05-14 Vertex Pharmaceuticals Incorporated 1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
US20080221084A1 (en) * 2006-10-30 2008-09-11 Otsuka Pharmaceutical Co., Ltd. Method for reducing infarction using vasopressin antagonist compounds, and compositions and combinations therefor
US20090069295A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched conivaptan
EP2240029A4 (en) * 2008-01-07 2012-08-22 Synta Pharmaceuticals Corp COMPOUNDS FOR USE AGAINST INFLAMMATORY AND IMMUNOMIC DISEASES
WO2009102761A1 (en) * 2008-02-12 2009-08-20 Bristol-Myers Squibb Company 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
US20110086834A1 (en) * 2008-06-26 2011-04-14 Amgen Inc. Alkynyl alcohols as kinase inhibitors
WO2011052519A1 (ja) 2009-10-26 2011-05-05 大塚製薬株式会社 ベンズアゼピン化合物
US20150238502A1 (en) 2012-10-18 2015-08-27 University Of South Florida Compositions and Methods for Treating Stroke
CN103497195B (zh) * 2013-10-21 2016-01-27 北京科莱博医药开发有限责任公司 盐酸考尼伐坦新晶型及其制备方法
CN105310978A (zh) * 2014-08-04 2016-02-10 李峰 一种含有活性成分盐酸考尼伐坦的药物组合物及其制剂
CN105884778A (zh) * 2014-09-24 2016-08-24 李峰 一种化合物和制备方法
CN105153168A (zh) * 2015-09-29 2015-12-16 上海天慈国际药业有限公司 N-[4-(2-甲基-4,5-二氢-3H-咪唑并[4,5-d][1]苯并氮杂卓-6-甲酰基)苯基]-2-苯基苯甲酰胺盐酸盐的制备方法
CN106317060B (zh) * 2016-08-22 2019-02-15 山东罗欣药业集团恒欣药业有限公司 一种盐酸考尼伐坦的制备方法
WO2019036024A1 (en) 2017-08-17 2019-02-21 Bristol-Myers Squibb Company 2- (1,1'-BIPHENYL) -1H-BENZO [D] IMIDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS AGONISTS OF APELIN AND APJ FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
EP4253367A4 (en) * 2020-11-26 2024-10-23 Shanghai Jemincare Pharmaceuticals Co., Ltd. NOVEL BENZAZEPINESPIRO DERIVATIVE
CN115427048A (zh) 2021-03-05 2022-12-02 上海济煜医药科技有限公司 新型苯并氮杂卓并环衍生物
KR102801544B1 (ko) 2023-07-27 2025-04-25 김주형 논슬립 기능을 구비한 자외선 차단 안면 보호커버
WO2025085662A1 (en) 2023-10-17 2025-04-24 Vanderbilt University Compounds for tocolytic use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011628A (en) * 1988-06-15 1991-04-30 Givaudan Corporation N,N'-diarylbenzamidines useful as ultraviolet light absorbers
ATE80610T1 (de) * 1988-06-15 1992-10-15 Givaudan & Cie Sa Benzamidine, verwendbar als uv-lichtabsorptionsmittel.
US5225402A (en) * 1989-02-10 1993-07-06 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2905909B2 (ja) * 1991-04-19 1999-06-14 大塚製薬株式会社 バソプレシン拮抗剤
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
WO1991005549A1 (en) * 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
JPH03255077A (ja) * 1990-03-01 1991-11-13 Taiji Nakayama ピリミジン誘導体およびそれを有効成分とする血小板凝集阻止剤
TW198715B (no) * 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
JP3255077B2 (ja) * 1997-04-23 2002-02-12 日本電気株式会社 電話機

Also Published As

Publication number Publication date
AU3990697A (en) 1997-12-18
FI113178B (fi) 2004-03-15
HUT74582A (en) 1997-01-28
EP0709386A4 (en) 1997-06-25
NO960231D0 (no) 1996-01-19
UA64690C2 (en) 2004-03-15
DE69434032T2 (de) 2005-09-22
EP1097920B1 (en) 2004-09-22
DE69432632T2 (de) 2004-02-19
AU7195794A (en) 1995-02-20
FI960260A0 (fi) 1996-01-19
CA2167673A1 (en) 1995-02-02
KR100304331B1 (ko) 2001-11-22
RU2129123C1 (ru) 1999-04-20
EP1097920A1 (en) 2001-05-09
AU683483B2 (en) 1997-11-13
CA2167673C (en) 2004-09-21
CN1127508A (zh) 1996-07-24
CN1040210C (zh) 1998-10-14
ATE239726T1 (de) 2003-05-15
EP0709386A1 (en) 1996-05-01
PL177738B1 (pl) 2000-01-31
NO306303B1 (no) 1999-10-18
PL312654A1 (en) 1996-04-29
DE69434032D1 (de) 2004-10-28
DE69432632D1 (de) 2003-06-12
EP0709386B1 (en) 2003-05-07
TW279163B (no) 1996-06-21
KR960703917A (ko) 1996-08-31
WO1995003305A1 (en) 1995-02-02
ATE277003T1 (de) 2004-10-15
ES2198418T3 (es) 2004-02-01
NZ268671A (en) 1997-09-22
US5723606A (en) 1998-03-03
ES2228405T3 (es) 2005-04-16
HU9600102D0 (en) 1996-03-28
US5856564A (en) 1999-01-05
FI960260A7 (fi) 1996-01-19

Similar Documents

Publication Publication Date Title
NO960231D0 (no) Kondensert benzazepinderivat og farmasöytisk preparat derav
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
NO940789D0 (no) Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse
IS6348A (is) (1a,3a,5a)(3-amínómetýl bísýkló[3.2.0]hept-3-ýl)-ediksýra, lyfjasamsetningar og notkun efnasambandsins til framleiðslu á lyfjum
NZ234327A (en) Quinazoline derivatives and pharmaceutical compositions
FI953968A7 (fi) Antraniiliset happojohdannaiset
FI943948L (fi) Heterosykliset hiilihappojohdannaiset
FI944217A0 (fi) Substituoidut pipekoliinihappojohdannaiset HIV-proteaasin estäjinä
DE69021618D1 (de) Antagonisten von exzitatorischen Aminosäuren.
FI945776A7 (fi) Yhden astian menetelmä 3-kinolonikarboksyylihaapojohdannaisten valmistamiseksi
FI940659A7 (fi) Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia
DE69734321D1 (de) Non-peptidische vasopressin via antagonisten
NO921840D0 (no) Substituerte karboksylsyrederivater
FI944045L (fi) Aromaattisia karboksyylihappojohdannaisia
NO950477D0 (no) Aminosyrederivater
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
FI941149A0 (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
FI895461A7 (fi) Psykotrooppisesti vaikuttavat pyrrolidiini-2-karboksyylihappojohdannaiset
MA23133A1 (fr) Derives d'acide d'acyloxyhexanoique .
NO952713D0 (no) Fremgangsmåte for fremstilling av substituerte indolonderivater
ITMI913510A0 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
NO912167L (no) Fremgangsmaate for fremstilling av ftalsyreanhydrid-derivater.
HUT77174A (hu) Heterociklusos csoporttal szubsztituált 3-(indol-3-il)-akrilsav-származékok, mint NMDA antagonisták, és a vegyületeket tartalmazó gyógyszerkészítmények
ES2080445T3 (es) Derivados de ursano, su preparacion y formulaciones farmaceuticas de los mismos.
FI944128A7 (fi) Menetelmä N-(2-pyrimidyyli)piperatsinyyli-butyyli-imidien valmistamiseksi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees